CNRS Nantes University US2B US2B
home |  start a new run |  job status |  references&downloads |  examples |  help  

Should you encounter any unexpected behaviour,
please let us know.
 elNémo has been hacked on november 27th.
It has been moved away and runs again.
**Still some additional cleaning from time to time**
Sorry for the inconvenience.


***  IMMUNE SYSTEM 14-NOV-18 6N2U  ***

<R2> analysis for 2604131021151763097

---  normal mode 80  ---

This page gives a visualization of the normalized mean square displacement <R2> of all C-alpha atoms in the protein that are associated to this mode (black bars). The three components of the corresponding eigenvector are shown on the left (colored bars). Here is the raw data for <R2> and for the eigenvector (shift-click on the links for download).

XYZresidue<R2><R2>max = 0.0759
LYS 10.0691
GLU 20.0243
LEU 30.0402
ARG 40.0739
CYS 50.0373
GLN 60.0373
CYS 70.0495
ILE 80.0332
LYS 90.0249
THR 100.0035
TYR 110.0064
SER 120.0088
LYS 130.0153
PRO 140.0043
PHE 150.0061
HIS 160.0304
PRO 170.0148
LYS 180.0295
PHE 190.0120
ILE 200.0055
LYS 210.0162
GLU 220.0118
LEU 230.0174
ARG 240.0241
VAL 250.0161
ILE 260.0116
GLU 270.0392
SER 280.0374
GLY 290.0759
PRO 300.0155
HIS 310.0562
CYS 320.0215
ALA 330.0127
ASN 340.0227
THR 350.0350
GLU 360.0184
ILE 370.0143
ILE 380.0213
VAL 390.0057
LYS 400.0241
LEU 410.0189
SER 420.0063
ASP 430.0119
GLY 440.0240
ARG 450.0132
GLU 460.0194
LEU 470.0095
CYS 480.0143
LEU 490.0057
ASP 500.0070
PRO 510.0179
LYS 520.0162
GLU 530.0165
ASN 540.0194
TRP 550.0128
VAL 560.0078
GLN 570.0163
ARG 580.0188
VAL 590.0097
VAL 600.0055
GLU 610.0025
LYS 620.0053
PHE 630.0083
LEU 640.0161
LYS 650.0257
ARG 660.0178
ALA 670.0167
GLU 680.0183
ASN 690.0241

If you find results from this site helpful for your research, please cite one of our papers:

elNémo is maintained by Yves-Henri Sanejouand.
It was developed by Karsten Suhre.
Between 2003 and 2014, it was hosted by IGS (Marseille).
Between 2015 and 2025, it was hosted by US2B (Nantes).
Last modification: december 26th, 2025.